DRNA

Dicerna Pharmaceuticals, Inc. News Headlines

$14.33
*  
0.31
2.21%
Get DRNA Alerts
*Delayed - data as of Aug. 22, 2014 13:47 ET  -  Find a broker to begin trading DRNA now
Exchange: NASDAQ
Industry: Health Care
Community Rating:
View:    DRNA Real Time
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save stocks for next time
Viewing
Filtered By
Ordered By

Dicerna Pharmaceuticals (DRNA) Soars: Stock Rises 19.8% - Tale of the Tape
7/1/2014 9:39:00 AM - Zacks.com

Sector Update: Healthcare Narrowly Lower This Afternoon; Dicerna Pharmaceuticals Surges After Early Study of Liver Drug Supports Use
6/30/2014 12:58:44 PM - MT Newswires

Sector Update: Healthcare
6/30/2014 12:57:04 PM - MT Newswires

Dicerna Pharmaceuticals Inc. (DRNA) Is Climbing On Pre-Clinical Data
6/30/2014 9:49:00 AM - RTT News

Dicerna Pharma To Present At JMP Securities Conference; Webcast At 1:00 PM ET
6/24/2014 12:00:00 PM - RTT News

Timing is everything
4/21/2014 12:56:00 PM - Seeking Alpha

Miss Out On These Hot IPOs? Here's Your Second Chance
4/15/2014 10:00:00 AM - Investopedia

The Harder They Fall: High-Popping IPOs Hammered In Aftermarket Trading
4/11/2014 11:45:00 AM - Seeking Alpha

The harder they fall: high-popping IPOs hammered in aftermarket trading
4/10/2014 7:50:40 PM - Renaissance Capital

U.S. IPO Recap: Varonis Provides Data Security For Enterprises And Financial Security For Investors
3/4/2014 7:24:00 AM - Seeking Alpha

US IPO Recap: Varonis provides data security for enterprises and financial security for investors
3/3/2014 9:23:38 AM - Renaissance Capital

Biotechs Dominate IPO Calendar, But Most Post Negative Returns
2/6/2014 11:45:00 AM - Seeking Alpha

Biotechs dominate IPO calendar, but most post negative returns
2/6/2014 9:57:52 AM - Renaissance Capital

12 U.S. IPOs Planned For The Week Of Feb. 3
2/4/2014 1:28:00 PM - Seeking Alpha

Dicerna Gains 207% In Market Debut, Best Biotech First-Day Pop Since 2000
2/4/2014 1:05:00 PM - Seeking Alpha

US IPO Recap: Ultragenyx doubles and Dicerna triples in home-run week for biotech IPOs
2/3/2014 9:19:17 AM - Renaissance Capital

Biotech Boomlet Set To Smash IPO Record For Two-Week Period
2/2/2014 5:42:00 AM - Seeking Alpha

Dicerna gains 207% in market debut, best biotech first-day pop since 2000
1/30/2014 6:55:10 PM - Renaissance Capital

Biotech boomlet set to smash IPO record for two-week period
1/30/2014 6:36:48 PM - Renaissance Capital

Healthcare Stocks Ending on High Note; Dicerna Pharma Almost Triples in Value After $90 Mln IPO
1/30/2014 4:57:45 PM - MT Newswires

Sector Update: Healthcare
1/30/2014 4:56:37 PM - MT Newswires

IPO Preview: Dicerna Pharmaceuticals
1/30/2014 12:26:00 AM - Seeking Alpha

Dicerna Pharmaceuticals prices IPO at $15, above the upwardly revised range
1/29/2014 10:46:18 PM - Renaissance Capital

Dicerna Pharmaceuticals increases shares offered and range, deal size is now $84 million
1/28/2014 12:28:01 PM - Renaissance Capital

6 U.S. IPOs Planned For The Week Of January 27
1/27/2014 9:30:00 AM - Seeking Alpha